1. Home
  2. BMRA vs PRPO Comparison

BMRA vs PRPO Comparison

Compare BMRA & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMRA
  • PRPO
  • Stock Information
  • Founded
  • BMRA 1971
  • PRPO N/A
  • Country
  • BMRA United States
  • PRPO United States
  • Employees
  • BMRA N/A
  • PRPO N/A
  • Industry
  • BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • PRPO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • BMRA Health Care
  • PRPO Industrials
  • Exchange
  • BMRA Nasdaq
  • PRPO Nasdaq
  • Market Cap
  • BMRA 9.8M
  • PRPO 8.8M
  • IPO Year
  • BMRA N/A
  • PRPO N/A
  • Fundamental
  • Price
  • BMRA $0.33
  • PRPO $5.08
  • Analyst Decision
  • BMRA
  • PRPO
  • Analyst Count
  • BMRA 0
  • PRPO 0
  • Target Price
  • BMRA N/A
  • PRPO N/A
  • AVG Volume (30 Days)
  • BMRA 86.2K
  • PRPO 9.8K
  • Earning Date
  • BMRA 08-23-2024
  • PRPO 08-15-2024
  • Dividend Yield
  • BMRA N/A
  • PRPO N/A
  • EPS Growth
  • BMRA N/A
  • PRPO N/A
  • EPS
  • BMRA N/A
  • PRPO N/A
  • Revenue
  • BMRA $5,405,208.00
  • PRPO $15,812,000.00
  • Revenue This Year
  • BMRA N/A
  • PRPO $75.18
  • Revenue Next Year
  • BMRA N/A
  • PRPO N/A
  • P/E Ratio
  • BMRA N/A
  • PRPO N/A
  • Revenue Growth
  • BMRA N/A
  • PRPO 61.64
  • 52 Week Low
  • BMRA $0.28
  • PRPO $4.31
  • 52 Week High
  • BMRA $2.13
  • PRPO $8.99
  • Technical
  • Relative Strength Index (RSI)
  • BMRA 23.13
  • PRPO 48.60
  • Support Level
  • BMRA $0.28
  • PRPO $4.32
  • Resistance Level
  • BMRA $0.39
  • PRPO $5.80
  • Average True Range (ATR)
  • BMRA 0.04
  • PRPO 0.43
  • MACD
  • BMRA -0.00
  • PRPO 0.06
  • Stochastic Oscillator
  • BMRA 27.68
  • PRPO 51.68

About BMRA Biomerica Inc.

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Europe market.

About PRPO Precipio Inc.

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

Share on Social Networks: